Intraoperative Neuromonitoring of Pelvic Autonomous Nerve Plexus During Total Mesorectal Excision
Rectal Neoplasms
About this trial
This is an interventional treatment trial for Rectal Neoplasms focused on measuring intraoperative, neuromonitoring, pelvic, autonomous, total, mesorectal, excision
Eligibility Criteria
Inclusion Criteria:
- Histologically confirmed rectal cancer
- Surgical resection with TME
- <90 years old
- Signed informed consent
Exclusion Criteria:
- Emergency operation
- Presence of pacemaker
- Partial mesorectal excision
- Sepsis or systematic infection
- Physical or mental impairment
- Pregnancy or nursing
- Insufficient preoperative data for the urogenital/ anorectal function
- Lack of compliance with the research process
Sites / Locations
- University Hospital of LarissaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
pIONM
Control
In the experimental group pIONM will be performed intraoperatively. For the implementation of pIONM, a special device, that allows simultaneous monitoring of sphincter signals and bladder manometry, will be introduced. This device will employ the placement of a bipolar electrode in the internal and external anal sphincter. Moreover, another electrode will be placed on the surrounding tissues. For bladder manometry, the catheter will be connected to the pressure sensor, and subsequently to the pIONM monitor. Intraoperatively, depending on the approach (open or laparoscopic), the respective bipolar stimulator will be used. Prior to the initiation of pIONM, urinary bladder will be drained and filled with 200 ml R/L. The pIONM parameters will be the following: 1-25 milliampere current, 30 Hz frequency and 200 μs monophasic pulses.
In the control group pIONM will not be performed intraoperatively